Patents by Inventor Jong-Soon Kang

Jong-Soon Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8975241
    Abstract: There is provided a composition for preventing and treating obesity including high water-soluble ?-cyclodextrin derivatives as an effective component. Specifically, the composition including the high water-soluble ?-cyclodextrin derivatives, especially, 2-hydroxypropyl-?-cyclodextrin (HP-?-CD, HPBCD) has effects on suppressing an increase in body weight induced by a high fat diet, suppressing appetite through decreasing an amount of dietary intake, decreasing body fat, decreasing liver weight, and significantly decreasing a sharp increase of blood sugar induced by intaking glucose and maltose on an empty stomach so that it can be useful for preventing and treating obesity, preventing and treating various diseases induced by obesity, and suppressing a sharp increase of blood sugar after dinner.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: March 10, 2015
    Assignee: Song Ho Biomed Co., Ltd.
    Inventors: Gyoon-Hee Han, Yong Seok Choi, Sang-Bae Han, Jong-Ho Lee, Hwan-Mook Kim, Song-Kyu Park, Ki-Ho Lee, Jong-Soon Kang, Ki-Hoon Lee, Chang-Woo Lee
  • Publication number: 20120196831
    Abstract: There is provided a composition for preventing and treating obesity including high water-soluble ?-cyclodextrin derivatives as an effective component. Specifically, the composition including the high water-soluble ?-cyclodextrin derivatives, especially, 2-hydroxypropyl-?-cyclodextrin (HP-?-CD, HPBCD) has effects on suppressing an increase in body weight induced by a high fat diet, suppressing appetite through decreasing an amount of dietary intake, decreasing body fat, decreasing liver weight, and significantly decreasing a sharp increase of blood sugar induced by intaking glucose and maltose on an empty stomach so that it can be useful for preventing and treating obesity, preventing and treating various diseases induced by obesity, and suppressing a sharp increase of blood sugar after dinner.
    Type: Application
    Filed: October 8, 2010
    Publication date: August 2, 2012
    Applicant: SONG HO BIOMED CO., LTD
    Inventors: Gyoon-Hee Han, Yong Seok Choi, Sang-Bae Han, Jong-Ho Lee, Hwan-Mook Kim, Song-Kyu Park, Ki-Ho Lee, Jong-Soon Kang, Ki-Hoon Lee, Chang-Woo Lee
  • Publication number: 20090087444
    Abstract: The present invention relates to a pharmaceutical composition for activating dendritic cells having polysaccharides from Angelica gigas Nakai as valid component. The angelan, polysaccharides separated from Angelica gigas Nakai, can improve the revelation of surface molecule of dendritic cells, the secret of cytokine of dendritic cells, the proliferation capability of T cells of dendritic cells, and the generation of cytokine such as IL-2.
    Type: Application
    Filed: September 29, 2006
    Publication date: April 2, 2009
    Inventors: Hwan-Mook Kim, Sang-Bae Han, Song-Kyu Park, Ki-Ho Lee, Jong-Soon Kang, Ki-Hoon Lee, Jee-Youn Kim, Chang-Woo Lee
  • Publication number: 20090048328
    Abstract: This invention relates to a composition for the prevention and treatment of acute graft-versus-host disease comprising prodigiosin isolated from Serratia marcescence B-1231 KCTC 0386BP, as an effective ingredient. The prodigiosin is immunosup-pressive by selectively suppressing the proliferation of T-cells through the suppression of the expression of IL-2 receptors, which is needed for the activation of T-cells. Prodigiosin can be used either alone or in conjunction with cyclosporin A for greater effect, since the two substances have different mode of actions. These make prodigiosin effective for the prevention and treatment of acute graft-versus-host disease.
    Type: Application
    Filed: July 10, 2006
    Publication date: February 19, 2009
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hwan Mook Kim, Sang-Bae Han, Chang-Woo Lee, Ki-Hoon Lee, Sung-Kyu Park, Ki-Ho Lee, Jong-Soon Kang, Won-Kee Yoon, Young-Kook Kim
  • Patent number: 7462739
    Abstract: Disclosed are ceramide derivatives represented by the following formula 1 or 2, a method for preparing the same, and a therapeutic agent for treating atopic dermatitis including the ceramide derivatives as active ingredients: wherein, R1 and R2 are each independently straight or branched alkyl groups having 4 to 22 carbon atoms. The therapeutic agent for treating atopic dermatitis including the ceramide derivatives as active ingredients according to the present invention may be useful to treat atopic dermatitis, or treat other skin diseases that are required for improving skin inflammations or suppressing epidermal proliferation, by suppressing or improving inflammatory conditions in the atopic dermatitis in addition to giving immunoregulatory functions, and suppressing or improving skin disorders, for example epidermal proliferation that is generally observed in the atopic dermatitis.
    Type: Grant
    Filed: December 26, 2007
    Date of Patent: December 9, 2008
    Assignee: Neopharm Co., Ltd.
    Inventors: Byeong-Deog Park, Jong-Kyung Youm, Hyung-Sub Gwak, Mi-Jung Kwon, Hwan-Mook Kim, Jong-Soon Kang, Sang-Bae Han
  • Publication number: 20080161272
    Abstract: Disclosed are ceramide derivatives represented by the following formula 1 or 2, a method for preparing the same, and a therapeutic agent for treating atopic dermatitis including the ceramide derivatives as active ingredients: wherein, R1 and R2 are each independently straight or branched alkyl groups having 4 to 22 carbon atoms. The therapeutic agent for treating atopic dermatitis including the ceramide derivatives as active ingredients according to the present invention may be useful to treat atopic dermatitis, or treat other skin diseases that are required for improving skin inflammations or suppressing epidermal proliferation, by suppressing or improving inflammatory conditions in the atopic dermatitis in addition to giving immunoregulatory functions, and suppressing or improving skin disorders, for example epidermal proliferation that is generally observed in the atopic dermatitis.
    Type: Application
    Filed: December 26, 2007
    Publication date: July 3, 2008
    Inventors: Byeong-Deog Park, Jong-Kyung Youm, Hyung-Sub Gwak, Mi-Jung Kwon, Hwan-Mook Kim, Jong-Soon Kang, Sang-Bae Han